1. Anti-infection
  2. HBV
  3. HBV-IN-54

HBV-IN-54 是一种选择性的口服有效 HBV 抑制剂。HBV-IN-54 在 HepAD38 细胞 (EC50 = 0.020 μM,CC50 > 100 μM) 和 HLCZ01 细胞 (EC50 = 0.024 μM, CC50 > 100 μM) 中均表现出抗 HBV 活性,并能在体内抑制病毒复制。HBV-IN-54 展现出良好的理化性质与较高的血浆稳定性,适用于乙型肝炎 (HBV) 的相关研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

HBV-IN-54

HBV-IN-54 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

HBV-IN-54 is a selective and orally active HBV inhibitor. HBV-IN-54 exhibits anti-HBV activity in both HepAD38 cells (EC50 = 0.020 μM, CC50 > 100 μM) and HLCZ01 cells (EC50 = 0.024 μM, CC50 > 100 μM). HBV-IN-54 inhibits viral replication in vivo. HBV-IN-54 displays favorable physicochemical properties and high plasma stability. HBV-IN-54 can be used for research on Hepatitis B (HBV)[1].

体外研究
(In Vitro)

HBV-IN-54 (compound 35a) 能够稳定地结合于 HBV 核心蛋白,保持与 Trp-102、Thr-128 和 Leu-140 的氢键相互作用,并与 Ser-106、Thr-142 和 Asn-136 形成相互作用[1]
HBV-IN-54 (6 天) 在 HepAD38 细胞系中的 EC50 为 0.039 μM,CC50 为 53.11 μM,SI 为 1361.8[1]
HBV-IN-54 (0.3-100 μM,6 天) 在 HLCZ01 细胞系中具有抗 HBV 活性,EC50 约为 0.024 μM[1]
HBV-IN-54 (1 mg/mL,孵育 0-60 分钟) 在人肝微粒体中具有代谢稳定性,T1/2 = 30.8 min,C = 1 mg/mL,CLmint = 22.5 μL/min/mg protein,MPPGL = 48.8 mg protein/g tissue,OW = 25.7 g tissue/kg body weight,CLint,sce = 28.2 mL/min/kg[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay[1]

Cell Line: HLCZ01 Cells
Concentration: 0.3 μM, 10 μM, 30 μM, and 100 μM
Incubation Time: 3 days
Result: Exhibited minimal cytotoxicity at a concentration of 100 μM (inhibition rate 8.02%) and suppressed HBV DNA replication in a dose-dependent manner.
体内研究
(In Vivo)

HBV-IN-54 (compound 35a) (25 mg/kg,口服给药,每日一次,连续 21 天) 在 pAAV-HBV1.2 质粒诱导的 HBV 小鼠模型中表现出体内抗病毒活性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: pAAV-HBV1.2 plasmid (6 μg, i.v., once)-induced male C57BL/6J mice (6 week-old)[1]
Dosage: 25 mg/kg
Administration: i.g., once daily for 21 days , blood samples were collected every 3 days
Result: Reduced serum HBV DNA levels by 1.88 log10 IU/mL.
Reduced the number of HBcAg-positive cells by 40%.
Did not induce obvious drug-induced liver injury.
分子量

448.53

Formula

C22H26F2N4O2S

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
HBV-IN-54
目录号:
HY-179393
需求量: